PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Infectious Disease & Beleghata General Hospital, Kolkata, India. jaggs.nbmc@gmail.com.\', \'Department of Tropical Medicine, School of Tropical Medicine, Kolkata, India. jaggs.nbmc@gmail.com.\', \'Infectious Disease & Beleghata General Hospital, Kolkata, India.\', \'IICB-Translational Research Unit of Excellence, CSIR-Indian Institute of Chemical Biology, Kolkata, India.\', \'Academy of Scientific and Innovative Research, Ghaziabad, India.\', \'Division of Structural Biology & Bioinformatics, CSIR-Indian Institute of Chemical Biology, Kolkata, India.\', \'CSIR-Institute of Genomics and Integrative Biology, Delhi, India.\', \'Department of Pediatrics, Sagar Dutta Hospital & College of Medicine, Kolkata, India.\', \'Department of Immunohematology & Blood Transfusion, Medical College, Kolkata, India.\', \'Indian Statistical Institute, Kolkata, India.\', \'Department of Critical Care Medicine, Tata Medical Center, Kolkata, India.\', \'Department of Tropical Medicine, School of Tropical Medicine, Kolkata, India.\', \'IICB-Translational Research Unit of Excellence, CSIR-Indian Institute of Chemical Biology, Kolkata, India. Dipyaman@iicb.res.in.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41467-022-28064-7
?:doi
?:hasPublicationType
?:journal
  • Nature communications
is ?:pmid of
?:pmid
?:pmid
  • 35046397
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.582
?:rankingScore_hIndex
  • 198
is ?:relation_isRelatedTo_publication of
?:title
  • A phase 2 single center open label randomised control trial for convalescent plasma therapy in patients with severe COVID-19.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all